Manipal Hospitals Achieves ₹3,091 Crore Revenue in Q1FY27, EBITDA Up 26%

Manipal Hospitals has announced a significant financial performance for the first quarter of FY27, reporting a year-on-year revenue increase of 38.1% to ₹3,091 crore. This growth was accompanied by a 26.4% rise in EBITDA, reaching ₹749 crore. Despite a decline in profit after tax by 4.2% to ₹243 crore, largely due to post-tax interest costs related to the Sahyadri Hospitals acquisition, the adjusted profit after tax saw an increase of 30.9% when excluding these costs.

Growth in Patient Volumes and Occupancy

The hospital chain experienced an impressive rise in patient volumes, with inpatient admissions increasing by 38.8% and outpatient visits up by 26%. Occupancy rates also improved, climbing by 290 basis points to reach 65%, as compared to the previous year.

In terms of revenue per occupied bed (ARPOB), excluding the Sahyadri acquisition, the figure stood at ₹77,200 per day, marking an 8.7% year-on-year growth. When including Sahyadri, ARPOB was ₹71,500 per day, a slight increase of 0.7%.

Specialties and Sahyadri Acquisition Impact

Manipal Hospitals’ specialties, particularly in oncology and orthopedics, were key contributors to the revenue surge. Inpatient revenue from these specialties grew by 62% and 49%, respectively, reflecting the demand for complex care. The CONGO-R specialties saw a 45% year-on-year revenue increase, highlighting their growing significance within the hospital's portfolio.

The recently acquired Sahyadri Hospitals chain also contributed positively to the financials, with its revenue growing by 12.8% year-on-year and EBITDA rising by 18.7% during the quarter.

Management's Outlook

Dilip Jose, Managing Director & CEO of Manipal Hospitals, emphasized that the first quarter of FY27 marked a significant milestone as the company operated as a listed entity for the first time. Jose attributed the robust performance to the hospital's extensive network across India, sustained patient demand, and continued growth in high-acuity specialties. He highlighted the company's focus on integrating added capacity while maintaining high standards of clinical quality and operational discipline.